Buzz Stocks: Cisco Systems, Inc., Pep Boys-Manny Moe and Jack, and Neurometrix Inc

Today's stocks to watch include Cisco Systems, Inc. (CSCO), Pep Boys-Manny Moe and Jack (PBY), and Neurometrix Inc (NURO)

Dec 29, 2015 at 9:29 AM
facebook twitter linkedin


U.S. markets are set to open higher as oil prices recover. Among the equities in focus are tech titan Cisco Systems, Inc. (NASDAQ:CSCO), auto parts dealer Pep Boys-Manny Moe and Jack (NYSE:PBY), and medical device maker Neurometrix Inc (NASDAQ:NURO). 

  • A U.S. appeals court ruled that CSCO did not infringe on a Commil USA wifi technology patent, reversing a prior judgment worth $64 million. The good news has Cisco Systems, Inc. up 0.4% pre-market, as it tries to fight back from a 1.8% year-to-date deficit, settling Monday night at $27.31. Option traders have been more bearish than usual toward the stock. CSCO's 10-day put/call volume ratio of 0.64 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) outstrips all but 15% of comparable readings taken during the past year.
  • PBY is moving to terminate a buyout agreement with Bridgestone after its board determined Carl Icahn's latest offer -- valuing Pep Boys at $1 billion, or $18.50 per share -- is superior. The move has sent the shares 7% higher ahead of the open. This is more of the same for a stock that's soared over 43% to trade at $17.41 since its close on Oct. 23, just ahead of Bridgestone's initial takeover bid. Amid this rapid run-up, traders have been buying to open puts over calls at an accelerated clip, per Pep Boys-Manny Moe and Jack's 50-day put/call volume ratio of 0.39 -- registering in the 86th percentile of its annual range.
  • NURO is set to surge 26.5% at the open after the firm said it's launching a nerve conduction test in Mexico, which will be used to evaluate systemic neuropathies, common in patients with type 2 diabetes. The expected gap higher is a welcome change of pace for shareholders, who have watched the stock lose 70% of its value in 2015 to trade at $2.30 -- and hit a record low of $2.18 earlier this month. Despite this poor technical track record, both of the analysts following Neurometrix Inc rate it a "strong buy."
 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners